Takeda to acquire gammadelta therapeutics to accelerate development of allogeneic ΓΔt cell therapies addressing solid tumors

Osaka, japan, & london--(business wire)--takeda exercised its option to acquire gammadelta therapeutics, expanding takeda's immuno-oncology and innate immune cell therapy portfolio.

TAK Ratings Summary

TAK Quant Ranking